Carisma Therapeutics, Inc.
CARM
$0.06
$0.019.62%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.78M | 2.00M | 8.59M | 18.83M | 28.13M |
| Total Receivables | 1.64M | 579.00K | 1.21M | 2.86M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.41M | 1.63M | 717.00K | 340.00K | 504.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 51.00K | 89.00K | 3.44M | 1.79M | 5.50M |
| Total Current Assets | 5.87M | 4.30M | 13.95M | 23.83M | 34.14M |
|
|
|||||
| Total Current Assets | 5.87M | 4.30M | 13.95M | 23.83M | 34.14M |
| Net Property, Plant & Equipment | 684.00K | 717.00K | 2.00M | 6.43M | 7.71M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 208.00K | 208.00K |
| Total Assets | 6.55M | 5.01M | 15.95M | 30.46M | 42.06M |
|
|
|||||
| Total Accounts Payable | 5.57M | 4.76M | 3.25M | 2.08M | 1.73M |
| Total Accrued Expenses | 1.09M | 2.53M | 4.71M | 7.45M | 4.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 153.00K | 1.05M | 1.64M | 1.74M | 2.46M |
| Total Finance Division Other Current Liabilities | -- | 613.00K | 853.00K | 4.79M | 1.83M |
| Total Other Current Liabilities | -- | 613.00K | 853.00K | 4.79M | 1.83M |
| Total Current Liabilities | 6.81M | 8.95M | 10.45M | 16.06M | 10.56M |
|
|
|||||
| Total Current Liabilities | 6.81M | 8.95M | 10.45M | 16.06M | 10.56M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 609.00K | 648.00K | 687.00K | 744.00K | 857.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 41.42M | 41.48M | 41.57M | 41.77M |
| Total Liabilities | 7.42M | 51.02M | 52.62M | 58.37M | 53.18M |
|
|
|||||
| Common Stock & APIC | 279.04M | 278.61M | 278.18M | 277.67M | 276.82M |
| Retained Earnings | -279.90M | -324.62M | -314.85M | -305.58M | -287.94M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -867.00K | -46.01M | -36.66M | -27.91M | -11.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -867.00K | -46.01M | -36.66M | -27.91M | -11.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -867.00K | -46.01M | -36.66M | -27.91M | -11.13M |
|
|
|||||